Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT.
Am J Hematol. 2023 Nov;98(11):1685-1698. doi: 10.1002/ajh.27046. Epub 2023 Aug 7.
Am J Hematol. 2023.
PMID: 37548390
[Colorectal cancer].
Zhang C, Stampfl-Mattersberger M, Ruckser R, Sebesta C.
Zhang C, et al. Among authors: stampfl mattersberger m.
Wien Med Wochenschr. 2023 Jun;173(9-10):216-220. doi: 10.1007/s10354-022-00975-6. Epub 2022 Nov 8.
Wien Med Wochenschr. 2023.
PMID: 36348129
Review.
German.
Item in Clipboard
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group.
Leisch M, Pfeilstöcker M, Stauder R, Heibl S, Sill H, Girschikofsky M, Stampfl-Mattersberger M, Tinchon C, Hartmann B, Petzer A, Schreder M, Kiesl D, Vallet S, Egle A, Melchardt T, Piringer G, Zebisch A, Machherndl-Spandl S, Wolf D, Keil F, Drost M, Greil R, Pleyer L.
Leisch M, et al. Among authors: stampfl mattersberger m.
Cancers (Basel). 2022 May 17;14(10):2459. doi: 10.3390/cancers14102459.
Cancers (Basel). 2022.
PMID: 35626063
Free PMC article.
Item in Clipboard
Cite
Cite